Sorry, you need to enable JavaScript to visit this website.

Can Human Milk Oligosaccharides Modulate Allergic Response and Improve the Management of Cow’s Milk Protein Allergy?

One of the latest publications of the CINNAMON study, which cites the evidence for benefits of Human Milk Oligosaccharides (HMO) in infants with Cow’s Milk Protein Allergy (CMPA), is amongs the 7 most cited publications in the pediatric section of the journal Nutrients in 2022. Access to the publication

Join us on December 1st at the EAACI FAAM for a digital satellite symposium ”Can Human Milk Oligosaccharides Modulate Allergic Response and Improve the Management of Cow’s Milk Protein Allergy?” Experts will share more about the latest evidence for the benefits of HMO in the management of CMPA.

The symposium will be accessible to all healthcare professionals

Save the date here